SCHEMBL4010409

SCHEMBL4010409

CC(Br)Cc1ccc(Cl)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.61
SLC6A3 Q01959 2/20 0.61
SLC6A4 P31645 2/20 0.54
IDO1 P14902 2/20 0.42
ACACB O00763 1/20 0.41
TAAR1 Q96RJ0 2/20 0.40
HTR2A P28223 1/20 0.40
HRH1 P35367 1/20 0.40
HTR2B P41595 1/20 0.40
CHRNA4 P43681 1/20 0.40
MEN1 O00255 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ADRB2 P07550 1/20 0.39
PPARG P37231 2/20 0.39
PPARA Q07869 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL764989 0.80 SLC6A2 (0.67) SLC6A2SLC6A3SLC6A4IDO1HTR2A
SCHEMBL2765367 0.78 SLC6A4 (0.56) SLC6A2SLC6A3SLC6A4IDO1TAAR1
SCHEMBL2326795 0.78 SLC6A2 (0.64) SLC6A2SLC6A3SLC6A4IDO1ACACB
SCHEMBL11451578 0.78 SIGMAR1 (0.43) IDO1ACACBTAAR1HTR2AMEN1
SCHEMBL9790105 0.78 IDO1 (0.44) IDO1ACACBTAAR1SMN1; SMN2ALDH1A1
SCHEMBL2320829 0.77 SLC6A2 (0.57) SLC6A2SLC6A3SLC6A4IDO1ACACB
SCHEMBL6683952 0.77 SLC6A3 (0.52) SLC6A2SLC6A3SLC6A4IDO1ACACB
SCHEMBL2558920 0.77 SLC6A2 (0.57) SLC6A2SLC6A3SLC6A4IDO1ACACB
SCHEMBL21175025 0.77 TAAR1 (0.47) SLC6A2SLC6A3SLC6A4IDO1TAAR1
SCHEMBL22229845 0.76 SLC6A2 (1.00) SLC6A2SLC6A3SLC6A4TAAR1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074089-A2 ORGANIC COMPOUNDS Novartis AG (CH) 2009-07-01 EP disclosed
WO-2008048991-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2008-04-24 WO disclosed